Tracking the STRO option chain helps you see every strike and expiry on Sutro Biopharma Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Sutro Biopharma Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of STRO options activity at a glance. Use our scanner to monitor the STRO option chain in real time and filter for the STRO options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For STRO stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the STRO option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where STRO stock options are being actively traded and where they are not.
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials.
It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Sutro Biopharma Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen STRO options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of STRO stock options — let the full option chain come to you, pre-filtered and ready to trade.
